| Literature DB >> 28462147 |
Shridhar C Ghagane1, Sridevi I Puranik1,2, Vijay M Kumbar3, Rajendra B Nerli4, Sunil S Jalalpure3,5, Murigendra B Hiremath1, Shivayogeeswar Neelagund6, Ravindranath Aladakatti7.
Abstract
BACKGROUND: To determine the phytochemical constituents, antioxidant, and anticancer activities of Leea indica leaf extracts on DU-145 and PC-3 human prostate cancer cell lines.Entities:
Keywords: Leea indica; anticancer; antioxidant; phytochemical; prostate cancer
Year: 2017 PMID: 28462147 PMCID: PMC5395687 DOI: 10.1016/j.imr.2017.01.004
Source DB: PubMed Journal: Integr Med Res ISSN: 2213-4220
Preliminary phytochemical screening of .
| Constituent | Test | Chloroform | Ethyl acetate | Methanol | Ethanol | Aqueous |
|---|---|---|---|---|---|---|
| Iodine | – | – | – | – | – | |
| Wagner’s | – | – | + | – | ++ | |
| Dragendroff’s | – | – | + | – | ++ | |
| Pew’s | – | – | + | + | + | |
| Shinoda | – | – | ++ | + | ++ | |
| NaOH | – | – | – | + | – | |
| Keller-Killani | + | ++ | ++ | ++ | + | |
| Glycosides | – | + | – | – | – | |
| Conc. H2SO4 | – | ++ | ++ | ++ | ++ | |
| Molisch | ++ | ++ | ++ | ++ | ++ | |
| Ellagic acid | – | – | ++ | ++ | ++ | |
| Phenol | – | – | ++ | ++ | ++ | |
| Labat | + | ++ | – | – | – | |
| Foam test | – | – | – | + | + | |
| Salkowski’s | + | – | + | ++ | – | |
| Gelatine | – | – | ++ | + | ++ | |
| Lead acetate | – | + | ++ | ++ | ++ | |
| Bomtrager’s test | – | – | – | ++ | + | |
| – | – | + | + | ++ | ||
| – | + | ++ | ++ | ++ | ||
| – | – | – | – | – |
–, absent; +, moderately present; ++, high presence.
Fig. 1Ferric reducing/antioxidant power assay for extracts of .
Data is presented as mean standard error of the mean (n = 3). Statistical significance was assessed using one-way as compared with standard.
*p < 0.05.
Fig. 2Phosphomolybdenum assay for extracts of .
Data is presented as mean standard error of the mean (n = 3). Statistical significance was assessed using one-way as compared to standard group.
*p < 0.05.
Determination of percentage inhibition of 2, 2-diphenyl-1-picrylhydrazyl radical scavenging activity of .
| Concentration (mg) | Percentage of inhibition | |||
|---|---|---|---|---|
| Methanol | Ethanol | Aqueous | Standard: ascorbic acid | |
| 100 | 57.11 ± 0.43 | 43.87 ± 0.16 | 33.76 ± 0.14 | 62.45 ± 0.17 |
| 200 | 64.15 ± 0.49 | 45.05 ± 0.21 | 44.06 ± 0.18 | 66.96 ± 0.25 |
| 300 | 73.24 ± 0.29 | 67.75 ± 0.29 | 62.05 ± 0.32 | 75.03 ± 0.19 |
| 400 | 78.16 ± 0.15 | 70.84 ± 0.12 | 73.69 ± 0.11 | 82.15 ± 0.14 |
| 500 | 82.86 ± 0.25 | 80.01 ± 0.33 | 77.40 ± 0.12 | 90.78 ± 0.12 |
The values presented are mean ± standard deviation, n = 3. Results were analyzed using descriptive statistics.
Fig. 3(A) Cytotoxicity of .
Data is presented as mean standard error of the mean (n = 3). Statistical significance was assessed using one-way as compared to the control group and standard.
*p < 0.05.
** p < 0.01.
Fig. 4(A) Morphological changes showing inhibition of DU-145 prostate cancer cell lines, whereas no inhibition was observed on MEF-L929 normal cell line for 72 hours. (B) Morphological changes showing inhibition of PC-3 prostate cancer cell lines, whereas no inhibition was observed on MEF-L929 normal cell line for 72 hours. (C) Morphological changes of standard drug paclitaxel on DU-145 and PC-3 prostate cancer cell lines.
BL, membrane blebbing (magnification for DU-145 was 20 × and PC-3 was 40 × ); CSCellular shrinkage.
IC.
| Cells | Methanol | Ethanol | Aqueous |
|---|---|---|---|
| DU-145 | 529.44 ± 42.07 | 677.11 ± 37.01 | 875.22 ± 38.53 |
| PC-3 | 547.55 ± 33.52 | 631.99 ± 50.24 | 987.88 ± 50.06 |
| Standard: paclitaxel | 0.3 μM/mL | ||
The values presented are mean ± standard deviation, n = 3. Results were analyzed using descriptive statistics.